BACKGROUND: Recently, studies have been reported on the optimal immunohistochemical markers for subclassification of non-small cell lung carcinoma (NSCLC). The main pitfall in subclassification of NSCLC is small specimen with poorly differentiated area. In this study, we added newly proposed markers (e.g., napsin A, SOX2) to conventional markers (p63, TTF-1, CK5/6, and CK7) and evaluated optimal combination for subtyping of NSCLC, primarily focusing on the poorly differentiated area. METHODS: Eighty two resected NSCLCs with poorly differentiated areas were classified based on histologic findings. After histologic review, only poorly differentiated areas were selected and tissue microarrays were constructed to simulate small biopsy conditio...
Histopathologic classification of cancer in the lung is important for choice of treatment. Cytokerat...
Whether non-small cell lung carcinoma (NSCLC) unveiled by immunohistochemistry (IHC) has the same cl...
Introduction: Diagnosing Non-Small Cell Lung Carcinoma (NSCLC) by morphology on small biopsy specim...
Background & objectives: Accurate histopathological subtyping of non-small cell lung carcinoma (NSCL...
INTRODUCTION: More detailed typing of non-small cell lung cancer on small biopsy specimens is increa...
Background: Lung cancer is the leading cause of cancer-related deaths in the world. Primary lung car...
Introduction:More detailed typing of non-small cell lung cancer on small biopsy specimens is increas...
BACKGROUND: New developments in the treatment of lung cancer have necessitated the further histologi...
OBJECTIVES: Advancements in non-small cell lung cancer treatment based on targeted therapies have ma...
Histological subclassification of non-small cell lung cancer (NSCLC) has growing therapeutic impact....
The aim: to find the optimal combination of immunohistochemical markers for differential diagnosis a...
The aim: to find the optimal combination of immunohistochemical markers for differential diagnosis a...
Correct diagnosis of pulmonary tumors is essential for treatment decision and often relies on immuno...
AbstractIntroductionIn small biopsies standard morphology cannot specifically subtype the tumor. His...
Objectives: To assess immunohistochemical (IHC) stains differentially expressed between different ty...
Histopathologic classification of cancer in the lung is important for choice of treatment. Cytokerat...
Whether non-small cell lung carcinoma (NSCLC) unveiled by immunohistochemistry (IHC) has the same cl...
Introduction: Diagnosing Non-Small Cell Lung Carcinoma (NSCLC) by morphology on small biopsy specim...
Background & objectives: Accurate histopathological subtyping of non-small cell lung carcinoma (NSCL...
INTRODUCTION: More detailed typing of non-small cell lung cancer on small biopsy specimens is increa...
Background: Lung cancer is the leading cause of cancer-related deaths in the world. Primary lung car...
Introduction:More detailed typing of non-small cell lung cancer on small biopsy specimens is increas...
BACKGROUND: New developments in the treatment of lung cancer have necessitated the further histologi...
OBJECTIVES: Advancements in non-small cell lung cancer treatment based on targeted therapies have ma...
Histological subclassification of non-small cell lung cancer (NSCLC) has growing therapeutic impact....
The aim: to find the optimal combination of immunohistochemical markers for differential diagnosis a...
The aim: to find the optimal combination of immunohistochemical markers for differential diagnosis a...
Correct diagnosis of pulmonary tumors is essential for treatment decision and often relies on immuno...
AbstractIntroductionIn small biopsies standard morphology cannot specifically subtype the tumor. His...
Objectives: To assess immunohistochemical (IHC) stains differentially expressed between different ty...
Histopathologic classification of cancer in the lung is important for choice of treatment. Cytokerat...
Whether non-small cell lung carcinoma (NSCLC) unveiled by immunohistochemistry (IHC) has the same cl...
Introduction: Diagnosing Non-Small Cell Lung Carcinoma (NSCLC) by morphology on small biopsy specim...